We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Targets – Products

Product News

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring

Bio-Rad Laboratories, Inc. today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin, secukinumab and the secukinumab–interleukin 17A drug-target complex.
Product News

Ubiquigent Appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board

Ubiquigent Limited has announced the expansion of its Scientific Advisory Board with the appointments of Professor Helen Walden and Professor John Davis.
Product News

Orbit Discovery Awarded Innovate UK Grant To Expand High Throughput Cell-Based Functional Screening Platform Capabilities

Orbit Discovery Ltd. has been awarded a Smart grant by Innovate UK, the UK’s innovation agency.
Product News

Dolomite Bio Releases Hydrogel Reagent Kits for Agarose Encapsulation and 3D Cell Culture Research

Dolomite Bio launches new hydrogel-focused reagent kits, enabling high-throughput encapsulation of cells in hydrogel scaffolds.
Product News

Proteros Expands Oncology Collaboration and License Agreement With AstraZeneca

Under the expanded collaboration, Proteros will receive additional research funding, milestone payments plus royalties.
Product News

NanoTemper Technologies Launches Spectral Shift

NanoTemper Technologies has announced the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery.
Product News

Agilent Announces the Innovative Seahorse XF Pro Analyzer

Agilent Technologies Inc. has announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools.
Whitepaper

Research Tools for Anti-Cancer Drug Targets

Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.
Product

SomaScan Assay: The World's Largest Proteomic Platform

Discover more with the first and only technology that can measure 7,000 proteins over a broad range of concentrations. Built on 20 years of pioneering proteomics technology, The SomaScan Assay enables unprecedented biomarker and drug discovery and now, you can seamlessly transition from discovery to validation with new SomaScan panels and SomaSignal TM Tests bolstering the entire drug discovery and development pipeline, all via a straightforward fee-for-service model.
Product

Synthetic Immune Recruitment – A New Way To Fight Tumors

The utility and efficiency of the Octet® platform at characterizing covalent immune recruiter molecule function and their efficacy as modulators of protein proximity was demonstrated. Efficient in vitro validation further enables the potential acceleration of CIR translation to in vivo model validation and the clinic as a new class of synthetic tumor immunotherapeutic.
Advertisement